Novel Agent Hints at Bone Growth Boost Without Hematopoietic Risks

(MedPage Today) -- AUSTIN, Texas – A novel agent appeared to regulate bone growth signaling in early phase data that stirred hopes it could help osteoporosis and other diseases.
In a phase I study, KER-012 did not elevate hemoglobin or red...